Dexcom (DXCM)
NASDAQ:DXCM
Holding DXCM?
Track your performance easily

Dexcom (DXCM) Financial Statements

3,604 Followers

Dexcom Financial Overview

Dexcom's market cap is currently ―. The company's EPS TTM is $1.622; its P/E ratio is 42.19; Dexcom is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.00B$ 921.00M$ 1.03B$ 975.00M$ 871.30M
Gross Profit$ 626.70M$ 561.90M$ 656.60M$ 623.30M$ 546.40M
EBIT$ 191.60M$ 137.10M$ 251.10M$ 247.10M$ 168.20M
EBITDA$ 243.70M$ 189.60M$ 303.60M$ 295.30M$ 211.90M
Net Income Common Stockholders$ 143.50M$ 146.40M$ 256.30M$ 120.70M$ 115.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 939.20M$ 851.20M$ 566.30M$ 643.70M$ 1.19B
Total Assets$ 6.80B$ 6.48B$ 6.26B$ 6.60B$ 6.82B
Total Debt$ 2.54B$ 2.53B$ 2.54B$ 2.66B$ 3.31B
Net Debt$ 1.60B$ 1.68B$ 1.97B$ 2.02B$ 2.12B
Total Liabilities$ 4.36B$ 4.24B$ 4.20B$ 4.33B$ 4.72B
Stockholders Equity$ 2.43B$ 2.25B$ 2.07B$ 2.27B$ 2.10B
Cash Flow-
Free Cash Flow$ 213.30M$ 152.30M$ 81.10M$ 218.80M$ 131.30M
Operating Cash Flow$ 279.40M$ 209.20M$ 133.60M$ 269.20M$ 190.30M
Investing Cash Flow$ -188.90M$ 74.80M$ 414.90M$ -179.50M$ -555.90M
Financing Cash Flow$ -1.40M$ 4.70M$ -631.90M$ -637.40M$ 939.50M
Currency in USD

Dexcom Earnings and Revenue History

Dexcom Debt to Assets

Dexcom Cash Flow

Dexcom Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis